Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine‐1‐phosphate receptor 2 could protect visual function from impairment.

MLA

Xue, Jingfei, et al. “Alleviating Early Demyelination in Ischaemia/Reperfusion by Inhibiting Sphingosine‐1‐phosphate Receptor 2 Could Protect Visual Function from Impairment.” Brain Pathology, vol. 33, no. 5, Sept. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1111/bpa.13161.

APA

Xue, J., Lin, J., Liu, Z., Zhang, Q., Tang, J., Han, J., Wu, S., Liu, C., Zhao, L., Li, Y., & Zhuo, Y. (2023). Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine‐1‐phosphate receptor 2 could protect visual function from impairment. Brain Pathology, 33(5), 1–17. https://doi.org/10.1111/bpa.13161

Chicago

Xue, Jingfei, Jicheng Lin, Zhe Liu, Qi Zhang, Jiahui Tang, Jiaxu Han, Siting Wu, et al. 2023. “Alleviating Early Demyelination in Ischaemia/Reperfusion by Inhibiting Sphingosine‐1‐phosphate Receptor 2 Could Protect Visual Function from Impairment.” Brain Pathology 33 (5): 1–17. doi:10.1111/bpa.13161.